Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Post by Revtenon Nov 08, 2024 11:15am
104 Views
Post# 36303259

MORNING ACTION

MORNING ACTION
House Positions for C:EDT from 20241108 to 20241108
House Bought $Val Ave Sold $Val Ave Net $Net
1 Anonymous 9,500 5,402 0.569 500 282 0.564 9,000 -5,120
85 Scotia 7,000 4,060 0.58 0   7,000 -4,060
33 Canaccord 6,500 3,640 0.56 0   6,500 -3,640
2 RBC 4,500 2,565 0.57 1,000 560 0.56 3,500 -2,005
7 TD Sec 34,000 19,380 0.57 32,000 18,140 0.567 2,000 -1,240
9 BMO Nesbitt 24 14 0.583 0   24 -14
79 CIBC 3,500 1,960 0.56 3,500 2,025 0.579 0 65
36 Latimer 0   24 14 0.583 -24 14
80 National Bank 500 285 0.57 28,500 16,285 0.571 -28,000 16,000
TOTAL 65,524 37,306 0.569 65,524 37,306 0.569 0 0
TD in play 

The Financials are only a Smoke Screen which can be used to draw in Shares from Weak Hands......

When you consider the fact that bringing a product to FDA Approval can cost close to 1 Billion Dollar$ and Spectral is doing it under $150 Million we can be Proud to be Shareholders and especially this close to completion!

Dont be fooled....This Is A Screaming Buy at this level and a great opportunity to Buy or Add on any weakness...:)

All the best!
Rev
<< Previous
Bullboard Posts
Next >>